Hyper-Collaboration in Life Sciences Creates Supply Chain Opportunities
Logility
NOVEMBER 11, 2021
From repurposed therapies to novel vaccines, the normal timeline of R&D has been accelerated beyond measure.” — Dr. Steve Arlington, president of The Pistoia Alliance. Hyper-collaboration offers many benefits, including shared risk, lower costs, better access to funding and talent, more innovation capacity and improved transparency.
Let's personalize your content